Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.

by Monika Hebeisen, Almut Scherer, Raphael Micheroli, Michael J Nissen, Giorgio Tamborrini, Burkhard Möller, Pascal Zufferey, Pascale Exer, Adrian Ciurea
Published 2019-01-01

Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Man...

by Monika Hebeisen, Raphael Micheroli, Almut Scherer, Xenofon Baraliakos, Manouk de Hooge, Désirée van der Heijde, Robert Landewé, Kristina Bürki, Michael J Nissen, Burkhard Möller, Pascal Zufferey, Pascale Exer, Adrian Ciurea
Published 2020-01-01

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis

by Raphael Micheroli, Monika Hebeisen, Lukas M. Wildi, Pascale Exer, Giorgio Tamborrini, Jürg Bernhard, Burkhard Möller, Pascal Zufferey, Michael J. Nissen, Almut Scherer, Adrian Ciurea, on behalf of the Rheumatologists of the Swiss Clinical Quality Management Program
Published 2017-07-01